These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1176 related articles for article (PubMed ID: 16255055)
1. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
2. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
3. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860 [TBL] [Abstract][Full Text] [Related]
4. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974 [TBL] [Abstract][Full Text] [Related]
5. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Rodriguez W; Mold C; Kataranovski M; Hutt J; Marnell LL; Du Clos TW Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982 [TBL] [Abstract][Full Text] [Related]
6. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus. Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860 [TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007 [TBL] [Abstract][Full Text] [Related]
8. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels. Maeda T; Nomoto K J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Eivazova ER; McDonnell JM; Sutton BJ; Staines NA Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885 [TBL] [Abstract][Full Text] [Related]
10. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies. Margaritte C; Gilbert D; Brard F; Tron F J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030 [TBL] [Abstract][Full Text] [Related]
11. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene. Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828 [TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice. Hentati B; Sato MN; Payelle-Brogard B; Avrameas S; Ternynck T Eur J Immunol; 1994 Jan; 24(1):8-15. PubMed ID: 8020574 [TBL] [Abstract][Full Text] [Related]
13. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice. Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834 [TBL] [Abstract][Full Text] [Related]
14. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice. Fredriksen K; Osei A; Sundsfjord A; Traavik T; Rekvig OP Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573 [TBL] [Abstract][Full Text] [Related]
15. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid. Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582 [TBL] [Abstract][Full Text] [Related]
16. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase. Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328 [TBL] [Abstract][Full Text] [Related]
17. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice. Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377 [TBL] [Abstract][Full Text] [Related]
18. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Craig ML; Bankovich AJ; McElhenny JL; Taylor RP Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028 [TBL] [Abstract][Full Text] [Related]
20. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice. Mjelle JE; Kalaaji M; Rekvig OP Autoimmunity; 2009 Feb; 42(2):104-11. PubMed ID: 19005880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]